Skip to main content
. 2015 Jan-Mar;28(1):109–117.

Figure 2.

Figure 2

Evolution of model for end stage liver disease (MELD) score in naïve patients (n=37) with HBV decompensated cirrhosis under entecavir (ETV) or tenofovir (TDF)